Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
International Journal of Laboratory Hematology|January 31, 2024
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational studyMarie Didembourg, Sara Reda, Johannes Oldenburg, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?Hélène Haguet, Jonathan Douxfils, Christian Chatelain, et al.
Thrombosis and Haemostasis|March 23, 2012
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilateJonathan Douxfils, François Mullier, Séverine Robert, et al.
Thrombosis Research|September 26, 2012
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literatureJonathan Douxfils, François Mullier, Claire Loosen, et al.
International Journal of Laboratory Hematology|September 18, 2020
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratoryRomain Siriez, Jean-Michel Dogné, Robert Gosselin, et al.
Seminars in Thrombosis and Hemostasis|September 2, 2022
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C ResistanceLaure Morimont, Nathalie Donis, Céline Bouvy, et al.
JAMA Oncology|February 6, 2016
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysisJonathan Douxfils, Hélène Haguet, François Mullier, et al.
British Journal of Biomedical Science|July 29, 2025
The Growing Demand for Peer Review: Current Challenges and Potential ReformsPierpaolo Pellicori, Jonathan Douxfils, Robert J Mentz, et al.
Frontiers in Pharmacology|August 23, 2021
NETosis and the Immune System in COVID-19: Mechanisms and Potential TreatmentsConstant Gillot, Julien Favresse, François Mullier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2024
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent boosterJulien Favresse, Constant Gillot, Julien Cabo, et al.
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
International Journal of Laboratory Hematology|January 31, 2024
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational studyMarie Didembourg, Sara Reda, Johannes Oldenburg, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?Hélène Haguet, Jonathan Douxfils, Christian Chatelain, et al.
Thrombosis and Haemostasis|March 23, 2012
Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilateJonathan Douxfils, François Mullier, Séverine Robert, et al.
Thrombosis Research|September 26, 2012
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literatureJonathan Douxfils, François Mullier, Claire Loosen, et al.
International Journal of Laboratory Hematology|September 18, 2020
Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratoryRomain Siriez, Jean-Michel Dogné, Robert Gosselin, et al.
Seminars in Thrombosis and Hemostasis|September 2, 2022
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C ResistanceLaure Morimont, Nathalie Donis, Céline Bouvy, et al.
JAMA Oncology|February 6, 2016
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysisJonathan Douxfils, Hélène Haguet, François Mullier, et al.
British Journal of Biomedical Science|July 29, 2025
The Growing Demand for Peer Review: Current Challenges and Potential ReformsPierpaolo Pellicori, Jonathan Douxfils, Robert J Mentz, et al.
Frontiers in Pharmacology|August 23, 2021
NETosis and the Immune System in COVID-19: Mechanisms and Potential TreatmentsConstant Gillot, Julien Favresse, François Mullier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2024
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent boosterJulien Favresse, Constant Gillot, Julien Cabo, et al.
Pageof 23